Literature DB >> 11348297

Morphometric Analysis of the Epithelium of Mammary Fibroadenomas During the Proliferative and Secretory Phases of the Menstrual Cycle.

Mary Miyazawa Simomoto1, Afonso Celso Pinto Nazário, Luiz Henrique Gebrim, Manoel Jesus Simões, Edmund Chada Baracat, Geraldo Rodrigues De Lima.   

Abstract

Fibroadenoma of the breast is a benign neoplasia with a mixture of glandular and mesenchymal elements of high incidence and is mainly present in young women. This aspect and the presence of estrogen and progesterone receptors reinforce its hormone dependency. Recent studies have demonstrated that the proliferative activity of the mammary epithelium is significantly increased during the luteal phase. In order to assess whether fibroadenomas behave like the normal breast under the cyclic action of hormones we counted the number of mitoses and calculated the nuclear volume of epithelial cells in both the proliferative and luteal phases. We selected 20 women with clinically diagnosed fibroadenomas, 10 in the proliferative phase and 10 in the secretory phase. Our results showed no significant differences in mitotic index or nuclear volume between the proliferative and the luteal phases of fibroadenomas. We therefore conclude that the epithelium of fibroadenomas behaves like a true neoplasia whose regulation may occur via paracrine mechanisms, which in turn would explain its self-limited growth.

Entities:  

Year:  1999        PMID: 11348297     DOI: 10.1046/j.1524-4741.1999.98099.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  2 in total

1.  Analysis of human mammary fibroadenoma by Ki-67 index in the follicular and luteal phases of menstrual cycle.

Authors:  M F Rego; M A L H Navarrete; G Facina; R Falzoni; R Silva; E C Baracat; A C P Nazario
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

2.  Progesterone receptors A and B and estrogen receptor alpha expression in normal breast tissue and fibroadenomas.

Authors:  Gisele Branchini; Lolita Schneider; Rodrigo Cericatto; Edison Capp; Ilma Simoni Brum
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.